قالب وردپرس درنا توس
Home / Health / Kaiser is implementing phase 3 testing of the coronavirus vaccine in 1,400 adults in California and Oregon

Kaiser is implementing phase 3 testing of the coronavirus vaccine in 1,400 adults in California and Oregon



Updated


Kaiser Permanente has participated in the Phase 3 clinical trial to test candidate coronavirus vaccine currently being produced by Pfizer and BioNTech, and will seek to enroll 1,400 adults 18-85 years old in California and Oregon participates in research, a press release from health institutions states. The aim of the trial was to involve 30,000 patients in 120 locations around the world.


According to the Kaiser research database, a portion of these vaccine candidates will be administered in Northern California at the Santa Clara Medical Center and Sacramento Medical Center. Registration for the trial has not yet begun.

The study will be double-blind, in which half of the participating patients will be given a vaccine, called BNT162b2, and the other half will be given a placebo. Neither the patient nor the investigator will know what dosage participants received.



“Kaiser Permanente is in a very good position to tackle this public health emergency,” said Dr. Nicola Klein, director of the Kaiser Permanente Vaccine Research Center in Oakland. “We have been at the forefront of vaccine research for over 30 years and have been involved in clinical trials for almost every licensed vaccine in the United States. We know we can do our part. has significance in helping determine if the vaccine is effective in preventing COVID. -19 disease. “


The vaccine research will be conducted at three Kaiser research sites in the West Bank: the Research Division in Oakland, the Research & Evaluation Division in Pasadena and the Kaiser Permanente Medical Research Center in Portland, Ore.


The world does not currently have a reliable vaccine candidate believed to be resistant to SARS-CoV-2, the new coronavirus that causes COVID-19 respiratory disease. On Tuesday, Russian President Vladimir Putin announced he had approved the coronavirus vaccine for widespread use, despite cautious concerns from the international medical community that the vaccine was not ready for deployment. because the test has not yet been completed. Putin noted that his daughter was among the first to be vaccinated.

US President Donald Trump told the press on Tuesday that US health companies are bringing their vaccine candidates into phase 3 of trial and the federal government is contracting Johnson & Johnson, Sante Fe, Moderna and others to produce hundreds of millions of doses are ready to roll out as soon as the Food and Drug Administration approves them.


As he told the media, “[There’s] great premise in each of them. “

ADD CORONAVIRUS INSURANCE:

Sign up for ‘The Daily’ newsletter for the latest information on coronavirus here.

Wearing a neck can be worse than not wearing a mask, the researchers found
—SF Italian restaurant has converted into general store calling it quit
—’We hope that you will miss our brewery ‘: Armstrong Brewery in South San Francisco closed forever
—Bryan Cranston inspired Tom Hanks to reveal COVID-19 diagnosis, donating plasma
—SF spends more than $ 446 million on COVID responses, but will need additional funding after June 2021

Alyssa Pereira is culture editor at SFGate. Email: alyssa.pereira@sfgate.com | Twitter: @alyspereira




Source link